Hvsen Biotechnology Co., Ltd. (300871.SZ)
CNY 21.48
(-2.27%)
CNY 21.48
(-2.27%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 842.24 Million CNY | 6.55% |
| 2022 | 790.44 Million CNY | 16.07% |
| 2021 | 680.98 Million CNY | 836.67% |
| 2020 | 72.7 Million CNY | -3.8% |
| 2019 | 75.57 Million CNY | 202.31% |
| 2018 | 25 Million CNY | 2400.0% |
| 2017 | 1 Million CNY | 0.0% |
| 2016 | 1 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 1.11 Billion CNY | -22.95% |
| 2024 Q1 | 1.1 Billion CNY | 30.72% |
| 2024 Q2 | 1.16 Billion CNY | 5.77% |
| 2023 Q1 | 836.03 Million CNY | 5.77% |
| 2023 FY | 842.24 Million CNY | 6.55% |
| 2023 Q4 | 842.24 Million CNY | 0.52% |
| 2023 Q3 | 837.92 Million CNY | -6.17% |
| 2023 Q2 | 893.05 Million CNY | 6.82% |
| 2022 Q4 | 790.44 Million CNY | 6.11% |
| 2022 Q3 | 744.9 Million CNY | 11.52% |
| 2022 Q2 | 667.98 Million CNY | -3.29% |
| 2022 Q1 | 690.7 Million CNY | 1.43% |
| 2022 FY | 790.44 Million CNY | 16.07% |
| 2021 Q2 | 61.26 Million CNY | -3.81% |
| 2021 Q1 | 63.69 Million CNY | -12.39% |
| 2021 Q3 | 126.93 Million CNY | 107.19% |
| 2021 Q4 | 680.98 Million CNY | 436.46% |
| 2021 FY | 680.98 Million CNY | 836.67% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 FY | 72.7 Million CNY | -3.8% |
| 2020 Q4 | 72.7 Million CNY | -57.04% |
| 2020 Q3 | 169.23 Million CNY | 13.33% |
| 2020 Q2 | 149.33 Million CNY | 0.0% |
| 2019 Q2 | 74.52 Million CNY | 0.0% |
| 2019 Q4 | 75.57 Million CNY | 0.0% |
| 2019 FY | 75.57 Million CNY | 202.31% |
| 2018 FY | 25 Million CNY | 2400.0% |
| 2017 FY | 1 Million CNY | 0.0% |
| 2016 FY | 1 Million CNY | 0.0% |